TechBio Boost cohort 2025: Meet the innovators
Explore the groundbreaking start-ups and scale-ups that took part in the second TechBio Boost programme from June to December 2025. Discover how these companies are driving the next wave of London techbio innovation.
AI VIVO
Designs generative AI systems and the Organome Platform to simulate biology at target, organ and organism levels to aid in novel medicine development.
Concr
Concr applies advanced modelling and Bayesian AI to turn complex molecular and clinical data into clear predictions of therapeutic response and outcome for cancer patients.
Curenetics
Curenetics uses AI‑powered prediction tools to personalise cancer care by predicting a patient’s likely response to treatment.
Enhanced Fertility
Enhanced Fertility offers a data‑driven digital platform to speed up testing, diagnosis and personalised fertility treatment decisions for clinics.
Graphene Trace
Graphene Trace develops smart, graphene‑based pressure‑sensing fabrics to continuously monitor pressure distribution and help prevent pressure ulcers.
Kiin AI
Kiin AI is building virtual scientists to support end‑to‑end drug discovery experiment design, execution and interpretation using intelligent software.
Kiin Bio
Kiin Bio accelerates drug discovery with an AI‑native Virtual Scientist platform that unifies tools from literature review through bioinformatics and wet lab.
Linkgevity
Linkgevity is at the forefront of longevity science, dedicated to extending healthspan and improving quality of life through innovative drug discovery and advanced AI technology.
Mendelian
Mendelian is helping to end the diagnostic odyssey by bringing timely patient insights to primary care. They are building a future where every patient population can expect the right treatment, from the right specialist, at the right time.
MFX
MFX is developing the Cyto Engine™ to unblock this access. Accelerating development and powering manufacturing by combining scalable, automated bioprocessing with powerful analytics and data.
Microsol
Microsol is an aerosol technology startup dedicated to accelerating and advancing the development of orally inhaled and nasal drug products.
NeuroVirt
NeuroVirt is a medtech company with a mission to improve the road to rehabilitation. Their aim is to help people get better faster whilst playing games immersed in XR's beautiful environments.
Pathway Bio
Pathway Bio is a functional precision medicine company redefining how cancer treatment decisions are made. By combining multiomic profiling, AI-driven prediction, and ex vivo microcancer technology, they help clinicians validate therapies on the patient’s tumour — before treatment begins.
Queen Square Analytics
Queen Square Analytics offers comprehensive capabilities in contract research for neurological clinical trials, with a focus on multiple sclerosis (MS).